Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)-Reference-Cited by-同舟云学术

Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)

Published:2023-08-21 Issue:9 Volume:40 Page:857-868
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Mangin Dee^ORCID,Lamarche Larkin,Templeton Jeffrey A.,Salerno Jennifer,Siu Henry,Trimble Johanna,Ali Abbas,Varughese Jobin,Page Amy,Etherton-Beer Christopher

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

https://link.springer.com/content/pdf/10.1007/s40266-023-01055-z.pdf

Reference75 articles.

1. Grover A, Joshi A. An overview of chronic disease models: a systematic literature review. Glob J Health Sci. 2014;7(2):210–27. https://doi.org/10.5539/gjhs.v7n2p210.

2. Griffith LE, Gilsing A, Mangin D, Patterson C, Heuvel E, Sohel N, et al. Multimorbidity frameworks impact prevalence and relationships with patient-important outcomes. J Am Geriatr Soc. 2019;67:1632–40. https://doi.org/10.1111/jgs.15921.

3. Spencer-Bonilla G, et al. Patient work and treatment burden in type 2 diabetes: a mixed-methods study. Mayo Clin Proc Innov Qual Outcomes. 2021;5(2):359–67. https://doi.org/10.1016/j.mayocpiqo.2021.01.006.

4. Buffel du Vaure C, Ravaud P, Baron G, Barnes C, Gilberg S, Boutron I. Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis. BMJ Open. 2016;6(3):e010119. https://doi.org/10.1136/bmjopen-2015-010119.

5. Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65(10):1041–51. https://doi.org/10.1016/j.jclinepi.2012.05.005.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) hospital study: effect of a collaborative medication review on the number of current regular medicines for older hospital inpatients;Internal Medicine Journal;2024-08-29

2. Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach;Expert Review of Clinical Pharmacology;2024-08-02

3. Exploring Polypharmacy and Drug Interactions in Geriatric Patients: A Cross-Sectional Study from India;2024-07-16

4. Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation;BMC Primary Care;2024-06-11

5. Polypharmacy in Psychiatry: An In-depth Examination of Drug-drug Interactions and Treatment Challenges;Current Pharmaceutical Design;2024-06